Clinical Trials Directory

Trials / Completed

CompletedNCT00456755

Herbal Treatment for Perennial Allergic Rhinitis

A Herbal Formula (SBL) for the Treatment of Perennial Allergic Rhinitis: A Randomized, Double-blind, Placebo-controlled Clinical Trial

Status
Completed
Phase
Phase 2
Study type
Interventional
Enrollment
126 (actual)
Sponsor
Chinese University of Hong Kong · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Not accepted

Summary

Allergic rhinitis(AR) is one of the most common allergic disorders throughout the world.The conventional therapies are effective in alleviating symptoms but the efficacy are limited and not persistent. Furthermonre, the cost and side-effect are known defects. A classical Chinese herbal formula, has been used for AR for centries. Our study purpose is to evaluate the clinical efficacy and safety of this formula verus placebo in perennial allergic rhinitis (PAR). Hypothesis: the classical herbal formula would improve the symptoms of PAR patients and change some immunological parameters in the peripheral blood when comparing with the placebo.

Detailed description

It is a randomized, double-blind, placebo-controlled trial.

Conditions

Interventions

TypeNameDescription
DRUGShi-Bi-Lin4 weeks of treatment, dose of 1 g (two capsules), twice daily
OTHERPlacebo4 weeks of colormatched placebo capsules, dose of 1 g (two capsules), twice daily

Timeline

Start date
2004-03-01
Primary completion
2006-04-01
Completion
2006-04-01
First posted
2007-04-05
Last updated
2010-01-06
Results posted
2010-01-06

Locations

2 sites across 1 country: Hong Kong

Source: ClinicalTrials.gov record NCT00456755. Inclusion in this directory is not an endorsement.